GPC3, a membrane-bound heparan sulfate proteoglycan highly expressed in 70% of HCC patients but absent in normal adult tissues [38], is under clinical evaluation in 11 of 22 ongoing HCC CAR-T trials [39–41]. The gene discussed is CD44; the disease is hepatocellular carcinoma.